BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
November 30 2017 - 9:27AM
BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless
medical technology company focused on the delivery of health
information to improve quality of life and reduce cost of care,
announced today a partnership with Apple (NASDAQ:AAPL) to provide
cardiac monitoring services in conjunction with the Apple Heart
Study. The study, which launched today, is expected to
discover undiagnosed irregular heart rhythms, such as atrial
fibrillation, using the Apple Watch and the dedicated “Apple Heart
Study” App.
Joseph H. Capper, President and Chief Executive Officer of
BioTelemetry, Inc., commented: “We are extremely excited to be
participating in this potentially ground-breaking study. Too
often, the first indication of a cardiac arrhythmia is the
occurrence of a life-threatening event. The Apple initiative
will potentially benefit countless individuals who are unaware that
they may be at risk for serious health issues.”
About BioTelemetryBioTelemetry, Inc. is the
leading mobile and wireless medical technology company focused on
delivery of health information to save and improve lives while
reducing the cost of care. The Company provides cardiac
monitoring, mobile blood glucose monitoring, centralized medical
imaging, and original equipment manufacturing that serve both the
Healthcare and Clinical Research industries. More information
can be found at www.gobio.com.
Contact:BioTelemetry, Inc.Heather C. GetzInvestor
Relations800-908-7103investorrelations@biotelinc.com
Apple (NASDAQ:AAPL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Apple (NASDAQ:AAPL)
Historical Stock Chart
From Sep 2023 to Sep 2024